Protocol and Report Template Support

Req ID:  88072

Tranent, GB, EH33 2NE

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

Job Summary

We are seeking a Protocol and Report Template Support to work remotely on a one year fixed term contract.

The Protocol and Report Template Support will systematically transfer and analyse all Protocol and Report templates over the course of 2021. The Protocol and Report Template Support will also:

  • Transfer and identify differences in all report and protocol templates for assigned sites
  • Utilize high technical skillsets in Word and have a strong understanding of applying formatting with styles, linking, fields, references, and other requirements to templates and template sections
  • Collaborate with department team
  • Perform QC checks for other members of the team


The following are minimum requirements related to the Protocol and Report Template Support position:

  • University entrance standard educational qualifications. A degree is welcome, but not essential.
  • Experience in scientific data presentation, writing, editing, and proofreading preferred
  • An equivalent combination of education and experience may be accepted as a satisfactory substitute for the specific education and experience listed above.
  • Microsoft Word expertise in templates and template management
  • Ability to problem solve and provide a support network
  • Proven experience of working within given timescales with excellent attention to detail
  • Effective written and verbal communication skills


The salary for this position will be dependent on skills and experience.


About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.  Each year approximately 300 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.


About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.


With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased  to $2.62 billion.


At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.